Compounds > alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol
Page last updated: 2024-09-02

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and indazoles

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with indazoles in 1 studies

Compound Research Comparison

Studies
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Trials
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Recent Studies (post-2010)
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Studies
(indazoles)		Trials
(indazoles)		Recent Studies (post-2010) (indazoles)
90125,6095503,265

Protein Interaction Comparison

ProteinTaxonomyalpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol (IC50)indazoles (IC50)
Chain A, Cell Division Protein Kinase 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, Cell Division Protein Kinase 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, Cell Division Protein Kinase 2Homo sapiens (human)185

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furukawa, S; Hiramatsu, M; Kameyama, T; Karasawa, K; Mamiya, T; Nabeshima, T; Noda, A; Noda, Y; Yamada, K1

Other Studies

1 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and indazoles

ArticleYear
Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice.
    Neuropharmacology, 2000, Volume: 39, Issue:12

    Topics: Analgesics, Opioid; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Behavior, Animal; Brain Chemistry; Cyclic GMP; Enzyme Inhibitors; Guanidines; Indazoles; Male; Methylene Blue; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pentazocine; Phenazocine; Pyrimidines; Receptors, sigma

2000